|
|
|
|
|
À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
|
|
|
 | Çã°¡Á¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇÑ±Ý¾× |
[A15107121]
[º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
\0 ¿ø/1ml(2007.07.01)(ÇöÀç¾à°¡)
\12 ¿ø/1ml(2005.01.01)(º¯°æÀü¾à°¡)
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
|
| ºü¸¥Á¶È¸ |
|
| Á¦Ç°¼º»ó |
ÇÃ¶ó½ºÆ½º´¿¡ µç ÀÌ ¾àÀº Àû»öÀÇ µþ±âÇ⠽÷´Á¦ [Á¦ÇüÁ¤º¸ È®ÀÎ] |
| Æ÷À塤À¯Åë´ÜÀ§ |
1SYR |
| È¿´ÉÈ¿°ú |
[ÀûÀÀÁõ º° °Ë»ö]
´ÙÀ½ ÁúȯÀÇ ±âµµÆó¼â¼º Àå¾Ö¿¡ ÀÇÇÑ È£Èí°ï¶õµî ¿©·¯Áõ»óÀÇ ¿ÏÈ : ±â°üÁö õ½Ä, ¸¸¼º±â°üÁö¿°, Æó±âÁ¾, õ½Ä¼º±â°üÁö¿°
[Drugbank ÀÇ ¼ººÐÁ¤º¸¿¶÷] [Theophylline]
|
| ¾à¹°À½½Ä°£ »óÈ£ÀÛ¿ë |
[Á¶È¸]
|
| ¿ë¹ý¿ë·® |
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
[ÁÖ¼ººÐÄÚµå:236901ASY ¿¡ µû¸¥ ½É»çÁöħ¿¶÷]
[TDM ´ë»ó¾à¹°]
Theophylline
À¯È¿Ç÷û³óµµ: 8~20 §¶/§¢
µ¶¼ºÇ÷û³óµµ: 25 §¶/§¢
´ÙÀ½ÀÇ ¿ë·®À» ¼Ò¾ÆÀÇ °æ¿ì 1ÀÏ 3ȸ, ¼ºÀÎÀÇ °æ¿ì 1ÀÏ 3ȸ·Î ºÐÇÒ °æ±¸Åõ¿©ÇÑ´Ù.
1-9¼¼ : üÁß §¸´ç 3.0§¢(¹«¼öµ¥¿ÀÇʸ°À¸·Î¼ 16§·)-4.5§¢(¹«¼öµ¥¿ÀÇʸ°À¸·Î¼ 24§·)
10-16¼¼ : üÁß §¸´ç 2.25§¢(¹«¼öµ¥¿ÀÇʸ°À¸·Î¼ 12§·)-3.5§¢(¹«¼öµ¥¿ÀÇʸ°À¸·Î¼ 19§·)
17¼¼ÀÌ»ó¼ºÀÎ : üÁß §¸´ç 2.25§¢(¹«¼öµ¥¿ÀÇʸ°À¸·Î¼ 12§·)-2.4§¢(¹«¼öµ¥¿ÀÇʸ°À¸·Î¼ 13§·)
|
| ÁÖ¿ä¾à¹° »óÈ£ÀÛ¿ë |
[Á¶È¸]
|
| ±Ý±â |
- Å©»êƾ°è ¾à¹°¿¡ °ú¹ÎÁõ ȯÀÚ
- À§¡¤½ÊÀÌÁöÀå±Ë¾ç ȯÀÚ
- Å©»êƾ°è ¾à¹°¿¡ ´ëÇÑ ½ÉÇÑ ºÎÀÛ¿ëÀÇ º´·ÂÀÌ Àִ ȯÀÚ
|
| ½ÅÁßÅõ¿© |
- °£ÁúȯÀÚ
- °©»ó¼±±â´ÉÇ×ÁøÁõ ȯÀÚ
- ±Þ¼º ½Å¿µ ȯÀÚ
- ¿ïÇ÷¼º ½ÉºÎÀü ȯÀÚ
- °£Àå¾Ö ȯÀÚ
- ¼Ò¾Æ, °í·ÉÀÚ
- À§.½ÊÀÌÁöÀå±Ë¾çÀÇ º´·ÂÀÌ Àִ ȯÀÚ
- Àú»ê¼ÒÇ÷Áõ ȯÀÚ
- °íÇ÷¾Ð ȯÀÚ
- ºñÈļº ½É±Ùº´Áõ ȯÀÚ
- ºó¸Æ¼º ºÎÁ¤¸Æ ȯÀÚ
- ½É±Ù °æ»ö ȯÀÚ
|
| ÀÌ»ó¹ÝÀÀ |
- ¼ï:
À¯»çÇÑ ¾à(¾Æ¹Ì³ëÇʸ° ÁÖ»ç¾×)¿¡ ÀÇÇØ ¼ïÀÌ ¹ß»ýÇÑÀûÀÌ ÀÖ´Ù´Â º¸°í°¡ ÀÖ´Ù.
°ú¹ÎÁõ: ¶§¶§·Î ¹ßÁø, °¡·Á¿ò µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
Á¤½Å½Å°æ°è: ÈïºÐ, ºÒ¾È, µÎÅë, ¶§¶§·Î ºÒ¸é, ¾îÁö·¯¿ò, ÁøÁ¤, À̸í, ¼ÕÀÇ ¸¶ºñ°¨ µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ¶ÇÇÑ °ú·®Åõ¿©½Ã °æ·Ã, Çê¼Ò¸®, È¥¼ö µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
¼øÈ¯±â°è: ½É°èÇ×Áø, ¾È¸éÈ«Á¶, ¶§¶§·Î ºó¸Æ, ¾È¸éâ¹é, ±â¿Ü¼öÃà, Ç÷¾ÐÀúÇÏ, ¼øÈ¯Àå¾Ö, ºÎÁ¤¸Æ µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
¼Òȱâ°è: »óº¹ºÎÅë, ÅäÇ÷, ±¸¿ª.±¸Åä, ¶§¶§·Î ¼³»ç, º¹Åë, º¹ºÎÆØ¸¸°¨ µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
ºñ´¢±â°è: ´Ü¹é´¢, ¿äºÐºñ Áõ°¡°¡ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
´ë»çÀÌ»ó: Ç÷û ¿ä»êÄ¡ »ó½ÂÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
È£Èí±â°è: ºóÈ£ÈíÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
°£Àå: ¶§¶§·Î ALT, AST, ¾ËÄ®¶óÀÎÆ÷½ºÆÄŸÁ¦(ALP)ÀÇ »ó½Â µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
±Ù°ñ°Ý°è: µå¹É°Ô Ⱦ¹®±ÙÀ¶ÇØÁõÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¹Ç·Î CPK »ó½Âµî¿¡ ÁÖÀÇÇÒ °Í
±âŸ: ¿øÇüÅ»¸ðÁõ, °íÇ÷´çÁõ, ºÎÀûÀýÇÑ ADHÁõÈÄ, ºÎÁ¾ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
|
| »óÈ£ÀÛ¿ë |
- ´Ù¸¥ Å©»êƾ°è ¾à¹° ¶Ç´Â ÁßÃ߽Űæ°è ÈïºÐ¾à°úÀÇ º´¿ëÅõ¿©½Ã °úµµÇÑ ÁßÃ߽ŰæÀÚ±ØÀÛ¿ëÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¹Ç·Î ÀÌ·¯ÇÑ ¾à¹°°ú´Â º´¿ëÅõ¿©ÇÏÁö ¾Ê´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ¸ç ºÎµæÀÌÇÏ°Ô º´¿ëÅõ¿©ÇÏ´Â °æ¿ì¿¡´Â °¨·®ÇÏ´Â µî ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.
- ¿¡¸®½º·Î¸¶À̽Å, Ŭ¶ó¸®½º·Î¸¶À̽Å, ¿°»ê¸Þ½Ç·¹Æ¾, ¿°»êº£¶óÆÄ¹Ð, ³ë¸£Ç÷ϻç½Å, ÀÎÅÍÆä·Ð, Æ®¸®¾Æ¼¼Æ¿¿Ã·¹¾Èµµ¸¶À̽Å, Æ®¸®¾Ï½Ã³î·Ð, ½Ã¸ÞƼµò, ¿¡³ì»ç½Å, ½ÃÇÁ·ÎÇ÷ϻç½Å, Åä¼öÇ÷ϻç½Å, ¿°»êƼŬ·ÎÇǵò, ¾Ë·ÎǪ¸®³î, ÀÌÇÁ¸®Çöóº», ÇÁ·ÎÇÁ¶ó³î·Ñ, °æ±¸¿ë ÇÇÀÓ¾à, ·Ï½Ã½º·Î¸¶À̽Å, ÇÇÆä¹Ìµò»ê »ï¼öȹ°, »çÀÌŬ·Î½ºÆ÷¸°, Ƽ¾Æº¥´ÙÁ¹, ¿°»ê¾Æ¹Ì¿À´Ù·Ð, ¿°»êµôƼ¾ÆÁª µî°ú º´¿ëÅõ¿©½Ã ÀÌ ¾àÀÇ Ç÷Áß³óµµ°¡ »ó½ÂµÉ ¼ö ÀÖÀ¸¹Ç·Î ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.
- Æä³ë¹Ù¸£ºñÅ», ¸®ÆÊÇǽÅ, ¶õ¼ÒÇÁ¶óÁ¹ µî°ú º´¿ëÅõ¿©½Ã ÀÌ ¾àÀÇ Ç÷Áß³óµµ°¡ ÀúÇ쵃 ¼ö ÀÖÀ¸¹Ç·Î ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.
- Æä´ÏÅäÀÎ, Ä«¹Ù¸¶Á¦Çɰú º´¿ë½Ã ¼·ÎÀÇ Ç÷Á߳󵵸¦ ÀúÇϽÃŲ´Ù´Â º¸°í°¡ ÀÖÀ¸¹Ç·Î ÁÖÀÇÇÒ °Í
- ´ÙÀ½ÀÇ ±³°¨½Å°æÈïºÐ¾à(¥â-È¿´É¾à)°ú º´¿ëÅõ¿©½Ã ºÎÀÛ¿ëÀÌ Áõ°µÉ ¼ö ÀÖÀ¸¹Ç·Î, ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù :
¿°»êÀ̼ÒÇÁ·¹³¯¸°, ¿°»êŬ·»ºÎÅ×·Ñ, ¿°»êÆ©·ÎºÎÅ×·Ñ, À¯»êÅ׸£ºÎÅ»¸°, ¿°»êÇÁ·ÎÄ«Å×·Ñ µî
- ÀÌ ¾àÀÇ Åõ¿©ÈÄ, ¥â©ü-È¿´É¾à, ½ºÅ×·ÎÀ̵åÁ¦, ÀÌ´¢Á¦ ¹× Àú»ê¼ÒÇ÷ÁõÀ¸·Î ÀÎÇÑ Ç÷û KÄ¡ÀÇ ÀúÇÏÀÛ¿ëÀÌ ¾Ç鵃 ¼ö ÀÖÀ¸¹Ç·Î ÁßÁõ õ½Ä ȯÀÚÀÇ °æ¿ì¿¡´Â ƯÈ÷ ÁÖÀÇÇϰí Ç÷Á¤ KÄ¡¸¦ ¸ð´ÏÅÍÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù.
- ÇÒ·Îź°úÀÇ º´¿ë¿¡ ÀÇÇØ ºÎÁ¤¸Æ µîÀÇ ºÎÀÛ¿ëÀÌ Áõ°ÇÏ´Â °æ¿ì°¡ ÀÖÀ¸¸ç ¿¬¼Óº´¿ë¿¡ ÀÇÇØ Å×·ÎÇʸ°ÀÇ Ç÷Áß³óµµ°¡ »ó½ÂÇÏ´Â °æ¿ì°¡ ÀÖ´Ù.
|
|
|
 | Á¤º¸¿ä¾à |
|
|
|
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
|
|
 | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |
|
|
| |
|
 | Á¦Ç°Á¤º¸ |
|
|
|
|
 | º¹¾àÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| LACTmed ¹Ù·Î°¡±â |
[¹Ù·Î°¡±â]
|
| ¾à¸®ÀÛ¿ë |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| Ãà¾àº¹¾àÁöµµ |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º¹¾àÁöµµ |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| ÀӺο¡´ëÇÑÅõ¿© |
| * |
ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù.
|
|
|   |
 FDA : Cµî±Þ
|
|
| * |
»ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
|
| * |
¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
|
|
|
½ÅÀå¾Ö, °£Àå¾Ö½Ã ¿ë·®Á¶Àý |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| Pharmacokinetics |
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
|
| º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸ |
[º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
|
| º¹¾à¶óº§ |
| À̹ÌÁö |
º¹¾à¼³¸í |
 |
¾îÁö·¯¿òÀÌ ÀÖÀ»¼ö ÀÖ½À´Ï´Ù. |
|
|
| * |
º¹¾àÀ̹ÌÁö´Â ¸ðµç º¹¾àÁöµµ »çÇ×À» Ç¥½ÃÇѰÍÀº ¾Æ´Ï¸ç, Ãß°¡ÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ°Å³ª ¼öÁ¤µÉ ¼ö ÀÖ½À´Ï´Ù. |
| * |
º¹¾àÀ̹ÌÁöÀÇ Ç¥½Ã¿©ºÎ´Â ½ÇÁ¦ ¾à¹°º¹¿ë½Ã Á߿䵵¿¡ µû¸¥°ÍÀº ¾Æ´Ï¸ç ´Ü¼øÈ÷ Çã°¡Á¤º¸»ó Ű¿öµå¸¦ ±âÁØÀ¸·Î µî·ÏµÇ¾ú½À´Ï´Ù. |
| * |
±ÍÇϰ¡ º¹¾àÀ̹ÌÁö Á¤º¸¸¦ ½Å·ÚÇÔÀº ÀüÀûÀ¸·Î ±ÍÇÏÀÇ Ã¥ÀÓÀÔ´Ï´Ù. µå·°ÀÎÆ÷´Â ÀÌ¿¡ ´ëÇÑ ¾î¶°ÇÑ º¸Áõµµ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
| º¸°ü»ó ÁÖÀÇ |
|
| Á¶Á¦½Ã ÁÖÀÇ |
|
|
|
 | ½É»çÁ¤º¸ |
|
|
|
|
 | ÇмúÁ¤º¸ |
|
|
| Ç׸ñ |
³»¿ë |
| DUR (ÀǾàǰ»ç¿ëÆò°¡) |
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
|
| µ¶¼ºÁ¤º¸ |
Theophylline¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â
Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do |
| Mechanism of Action |
Theophylline¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Theophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. Theophylline competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Theophylline also binds to the adenosine A2B receptor and blocks adenosine mediated bronchoconstriction.
|
| Pharmacology |
Theophylline¿¡ ´ëÇÑ Pharmacology Á¤º¸ Theophylline, an xanthine derivative chemically similar to caffeine and theobromine, is used to treat asthma and bronchospasm. Theophylline has two distinct actions in the airways of patients with reversible (asthmatic) obstruction; smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., non-bronchodilator prophylactic effects).
|
| Metabolism |
Theophylline¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Cytochrome P450 1A2 (CYP1A2)Adenosine deaminaseCytochrome P450 2E1 (CYP2E1)
|
| Protein Binding |
Theophylline¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ 40%, primarily to albumin.
|
| Half-life |
Theophylline¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ 8 hours
|
| Absorption |
Theophylline¿¡ ´ëÇÑ Absorption Á¤º¸ Theophylline is rapidly and completely absorbed after oral administration in solution or immediate-release solid oral dosage form.
|
| Pharmacokinetics |
Theophylline anhydrousÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
- Èí¼ö: °æ±¸
- Oxtriphyline(64% theophylline) : Á¦Çü¿¡ µû¶ó 75-100%±îÁö º¯ÇÑ´Ù.
- Theophylline : Á¦Çü¿¡ µû¶ó 100%±îÁö Èí¼öµÊ
- ºÐÆ÷
- Vd = 0.45L/kg
- ¸ðÀ¯·Î °ÅÀÇ Ç÷Áß³óµµ¿Í °°Àº Á¤µµ·Î ºÐÆ÷Çϸç Źݵµ Åë°ú


- ´ë»ç : °£¿¡¼ demethylation, oxidation
- ¹Ý°¨±â : ³ªÀÌ, °£ ±â´É, ½É ±â´É, Æó Áúȯ, Èí¿¬·Â¿¡ µû¶ó ¸Å¿ì ´Ù¾ç
- ¼Ò½Ç : ¼Òº¯
- ¼ºÀÎÀº 10%°¡ ¹Ìº¯Èü·Î ¹è¼³µÇ°í ½Å»ý¾Æ´Â ´õ ¸¹Àº ¾ç(50%±îÁö)ÀÌ ¹Ìº¯Èü·Î ½Å¹è¼³µÈ´Ù.
|
| Biotransformation |
Theophylline¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic. Biotransformation takes place through demethylation to 1-methylxanthine and 3-methylxanthine and hydroxylation to 1,3-dimethyluric acid. 1-methylxanthine is further hydroxylated, by xanthine oxidase, to 1-methyluric acid. About 6% of a theophylline dose is N-methylated to caffeine. Caffeine and 3-methylxanthine are the only theophylline metabolites with pharmacologic activity.
|
| Toxicity |
Theophylline¿¡ ´ëÇÑ Toxicity Á¤º¸ Symptoms of overdose include seizures, arrhythmias, and GI effects.
|
| Drug Interactions |
Theophylline¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available
|
CYP450 Drug Interaction |
[CYP450 TableÁ÷Á¢Á¶È¸] Theophylline¿¡ ´ëÇÑ P450 table
SUBSTRATES
CYP 1A2
clozapine
cyclobenzaprine
imipramine
mexiletine
naproxen
riluzole
tacrine
**theophylline**
INHIBITORS
CYP 1A2
cimetidine
fluoroquinolones
fluvoxamine
ticlopidine
INDUCERS
CYP 1A2
tobacco
|
| Food Interaction |
Theophylline¿¡ ´ëÇÑ Food Interaction Á¤º¸ Avoid alcohol.Take with food.Avoid excessive quantities of coffee or tea (Caffeine).
|
| Drug Target |
[Drug Target]
|
| SNP Á¤º¸ |
Name:Theophylline (DB00277)
Interacting Gene/Enzyme:Cytochrome P450 1A2 (Gene symbol = CYP1A2) Swissprt P05177
SNP(s):-2964G>A (A Allele)
Effect:Poor metabolizer, lower dose requirement
Reference(s):Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S: Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther. 2003 May;73(5):468-74. [PubMed]
|
| Description |
Theophylline¿¡ ´ëÇÑ Description Á¤º¸ A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3&
|
| Dosage Form |
Theophylline¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Elixir OralLiquid OralSolution IntravenousTablet OralTablet, extended release Oral
|
| Drug Category |
Theophylline¿¡ ´ëÇÑ Drug_Category Á¤º¸ Bronchodilator AgentsPhosphodiesterase InhibitorsRespiratory Smooth Muscle RelaxantsVasodilator Agents
|
| Smiles String Canonical |
Theophylline¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CN1C(=O)N(C)C2=C(NC=N2)C1=O
|
| Smiles String Isomeric |
Theophylline¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CN1C(=O)N(C)C2=C(NC=N2)C1=O
|
| InChI Identifier |
Theophylline¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)/f/h8H
|
| Chemical IUPAC Name |
Theophylline¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 1,3-dimethyl-7H-purine-2,6-dione
|
| Drug-Induced Toxicity Related Proteins |
THEOPHYLLINE ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:Renin Drug:theophylline Toxicity:low blood pressure . [¹Ù·Î°¡±â] Replated Protein:Acid sphingomyelinase-like phosphodiesterase Drug:Theophylline Toxicity:emetic side effect. [¹Ù·Î°¡±â] Replated Protein:Alanine aminotransferase Drug:theophylline Toxicity:metabolic acidosis. [¹Ù·Î°¡±â]
|
|
|
 | »ç¿ëÀÚÄÁÅÙÃ÷ |
|
|
|
|
|
-
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2023-01-03
-
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
|
|
¾Ë¸² |
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù. |
|
°æ°í |
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
|
|
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
[ÀǾàǰº´¿ë/¿¬·É´ë±Ý±â °í½Ã±Ù°Å·Î ¹Ù·Î°¡±â] Á¦¸ñ ¾øÀ½
2008³â 8¿ù 1ÀÏ ¾à°¡ÈÀÏ»ó 8¿ù´Þ ½Å±ÔµîÀç ¹× »èÁ¦µÇ´Â ǰ¸ñ Æ÷ÇÔÇÑ º´¿ë¿¬·É ±Ý±â ǰ¸ñ¸®½ºÆ® ±âÁØ
1. ÇöÀç °Ë»öÇÑ Á¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â Á¦Ç° Á¸Àç¿©ºÎ ¹× °Ë»ö
ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 Á¦Ç°³»¿ª °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
2. ¿¬·É´ë±Ý±â Á¸Àç¿©ºÎ
ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ ¿¬·É±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
|